News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
831,491 Results
Type
Article (85608)
Company Profile (700)
Press Release (745183)
Section
Business (232246)
Career Advice (4106)
Deals (39645)
Drug Delivery (116)
Drug Development (90650)
Employer Resources (194)
FDA (17973)
Job Trends (17274)
News (395560)
Policy (39620)
Tag
Academia (2974)
Alliances (56461)
Alzheimer's disease (1333)
Approvals (17881)
Artificial intelligence (153)
Bankruptcy (394)
Best Places to Work (12516)
Biotechnology (480)
Breast cancer (128)
Cancer (1171)
Cardiovascular disease (109)
Career advice (3513)
Cell therapy (269)
Clinical research (71537)
Collaboration (419)
Compensation (207)
COVID-19 (2801)
C-suite (105)
Data (1156)
Diabetes (166)
Diagnostics (6676)
Earnings (94730)
Employer resources (167)
Events (126778)
Executive appointments (325)
FDA (18535)
Funding (375)
Gene therapy (204)
GLP-1 (695)
Government (5048)
Healthcare (20708)
Infectious disease (2893)
Inflammatory bowel disease (121)
Interviews (807)
IPO (17597)
Job creations (5179)
Job search strategy (2855)
Layoffs (489)
Legal (10044)
Lung cancer (187)
Manufacturing (202)
Medical device (14402)
Medtech (14407)
Mergers & acquisitions (22100)
Metabolic disorders (470)
Neuroscience (1638)
NextGen Class of 2024 (7645)
Non-profit (5065)
Northern California (1516)
Obesity (270)
Opinion (244)
Patents (111)
People (64184)
Pharmaceutical (142)
Phase I (22020)
Phase II (31071)
Phase III (23419)
Pipeline (469)
Postmarket research (3540)
Preclinical (9957)
Radiopharmaceuticals (257)
Rare diseases (244)
Real estate (7373)
Regulatory (25958)
Research institute (2641)
Resumes & cover letters (648)
Southern California (1337)
Startups (4276)
United States (14562)
Vaccines (650)
Weight loss (220)
Date
Today (47)
Last 7 days (696)
Last 30 days (3824)
Last 365 days (38300)
2024 (35159)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (228)
Asia (49340)
Australia (8697)
California (3524)
Canada (1315)
China (265)
Colorado (157)
Connecticut (164)
Europe (113002)
Florida (473)
Georgia (127)
Illinois (413)
Indiana (216)
Kansas (103)
Maryland (630)
Massachusetts (2850)
Michigan (174)
Minnesota (296)
New Jersey (1003)
New York (1002)
North Carolina (839)
Northern California (1516)
Ohio (149)
Pennsylvania (871)
South America (1647)
Southern California (1337)
Texas (504)
Washington State (399)
831,491 Results for "pharma bio serv inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024
Pharma-Bio Serv, Inc. announced that revenues for the three and six months ended April 30, 2024 were approximately $2.4 and $4.8, million, respectively, a decrease of approximately $2.2 and $4.0 million when compared to the same periods last year.
June 14, 2024
·
2 min read
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024
Pharma-Bio Serv, Inc. (“Pharma-Bio Serv” or the “Company”) (OTCQB:PBSV) today announced that revenues for the quarter ended January 31, 2024 were approximately $2.4 million, a decrease of approximately $1.9 million when compared to the same period last year.
March 18, 2024
·
2 min read
Press Releases
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024
September 17, 2024
·
2 min read
Pharma-Bio Serv Announces Full Year Results - Jan 29, 2024
Pharma-Bio Serv, Inc. announced that revenues for the year ended October 31, 2023 were approximately $17.0 million, a decrease of approximately $2.4 million when compared to last year.
January 29, 2024
·
2 min read
Deals
Pharma-Bio Serv Announces Special Dividend - December 21, 2023
Pharma-Bio Serv, Inc. today announced that the Board of Directors approved a Special Dividend of $0.075 per share for Shareholders.
December 21, 2023
·
2 min read
Business
Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023
Pharma-Bio Serv, Inc. (“Pharma-Bio Serv” or the “Company”) (OTCQB:PBSV) today announced that net income for the three and nine months ended July 31, 2023 was approximately $0.5 and $1.4 million, respectively, an increase of approximately $0.2 and $0.5 million, when compared to the same periods last year.
September 14, 2023
·
2 min read
Pharm Country
Acasti Pharma to Attend BIO International Convention 2024
Acasti Pharma Inc. announced that the Company will be participating in the BIO International Convention taking place at the San Diego Convention Center from June 3-6, 2024.
May 28, 2024
·
6 min read
BioCapital
IGC Pharma to Attend BIO International Convention 2024
IGC Pharma, Inc, announced that the Company will be participating in the BIO International Convention taking place at the San Diego Convention Center from June 3-6, 2024.
May 21, 2024
·
3 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Business
Bio-Techne and Nikon Instruments Inc. Announce Partnership to Expand Access to Innovative Spatial Biology Services
Bio-Techne Corporation is pleased to announce that Lunaphore, part of Bio-Techne’s Spatial Biology Division, is partnering with Nikon Instruments Inc. to expand access to spatial biology services with the COMET™ platform for US-based biotech, pharma, and academic customers.
March 28, 2024
·
6 min read
1 of 83,150
Next
